Eli Lilly (LLY) Inventory Average (2009 - 2026)
Eli Lilly posted quarterly Inventory Average of $14.1 billion for Q1 2026, up 67.3% year-on-year from $8.5 billion in Q1 2025, and up 9.06% on a QoQ basis from $13.0 billion in Q4 2025.
Eli Lilly (LLY) has 18 years of Inventory Average data on file, last reported at $14.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average rose 67.3% year-over-year to $14.1 billion; the trailing twelve-month figure through Mar 2026 stood at $14.1 billion (up 67.3% YoY), and the FY2025 full-year result was $10.7 billion, up 59.66% from the prior year.
- Inventory Average for Q1 2026 stood at $14.1 billion, up from $13.0 billion in the prior quarter.
- Across five years, Inventory Average topped out at $14.1 billion in Q1 2026 and bottomed at $3.9 billion in Q3 2022.
- The 5-year median for Inventory Average is $5.9 billion (2024), against an average of $7.0 billion.
- The widest annual swing landed in 2022, when Inventory Average decreased 0.02%; it then soared 72.27% in 2025.
- A 5-year view of Inventory Average shows it stood at $4.1 billion in 2022, then soared by 31.12% to $5.3 billion in 2023, then soared by 40.98% to $7.5 billion in 2024, then surged by 72.27% to $13.0 billion in 2025, then rose by 9.06% to $14.1 billion in 2026.
- The last three Inventory Average figures came in at $14.1 billion (Q1 2026), $13.0 billion (Q4 2025), and $11.6 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | 2.74 Bn |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 14.14 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 14.39 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 5.00 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 6.57 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 6.21 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.84 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 10.66 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.72 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 7.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.14 Bn |
| Dec 31, 2025 | 12.96 Bn |
| Sep 30, 2025 | 11.60 Bn |
| Jun 30, 2025 | 10.16 Bn |
| Mar 31, 2025 | 8.45 Bn |
| Dec 31, 2024 | 7.52 Bn |
| Sep 30, 2024 | 6.97 Bn |
| Jun 30, 2024 | 6.29 Bn |
| Mar 31, 2024 | 5.94 Bn |
| Dec 31, 2023 | 5.34 Bn |
| Sep 30, 2023 | 4.85 Bn |
| Jun 30, 2023 | 4.67 Bn |
| Mar 31, 2023 | 4.43 Bn |
| Dec 31, 2022 | 4.07 Bn |
| Sep 30, 2022 | 3.87 Bn |
| Jun 30, 2022 | 3.90 Bn |
| Mar 31, 2022 | 3.89 Bn |
| Dec 31, 2021 | 3.90 Bn |
| Sep 30, 2021 | 3.87 Bn |
| Jun 30, 2021 | 3.74 Bn |
| Mar 31, 2021 | 3.82 Bn |
| Dec 31, 2020 | 3.77 Bn |
| Sep 30, 2020 | 3.43 Bn |
| Jun 30, 2020 | 3.21 Bn |
| Mar 31, 2020 | 3.15 Bn |
| Dec 31, 2019 | 3.15 Bn |
| Sep 30, 2019 | 3.14 Bn |
| Jun 30, 2019 | 3.12 Bn |
| Mar 31, 2019 | 3.08 Bn |
| Dec 31, 2018 | 3.61 Bn |
| Sep 30, 2018 | 4.14 Bn |
| Jun 30, 2018 | 4.39 Bn |
| Mar 31, 2018 | 4.54 Bn |
| Dec 31, 2017 | 4.43 Bn |
| Sep 30, 2017 | 4.38 Bn |
| Jun 30, 2017 | 4.19 Bn |
| Mar 31, 2017 | 3.80 Bn |
| Dec 31, 2016 | 3.72 Bn |
| Sep 30, 2016 | 3.82 Bn |
| Jun 30, 2016 | 3.75 Bn |
| Mar 31, 2016 | 3.59 Bn |
| Dec 31, 2015 | 3.43 Bn |
| Sep 30, 2015 | 3.35 Bn |
| Jun 30, 2015 | 3.13 Bn |
| Mar 31, 2015 | 2.86 Bn |
| Dec 31, 2014 | 2.79 Bn |
| Sep 30, 2014 | 3.02 Bn |
| Jun 30, 2014 | 3.08 Bn |
| Mar 31, 2014 | 2.95 Bn |
| Dec 31, 2013 | 2.95 Bn |
| Sep 30, 2013 | 2.85 Bn |
| Jun 30, 2013 | 2.65 Bn |
| Mar 31, 2013 | 2.61 Bn |
| Dec 31, 2012 | 2.60 Bn |
| Sep 30, 2012 | 2.44 Bn |
| Jun 30, 2012 | 2.37 Bn |
| Mar 31, 2012 | 2.36 Bn |
| Dec 31, 2011 | 2.41 Bn |
| Sep 30, 2011 | 2.69 Bn |
| Jun 30, 2011 | 2.82 Bn |
| Mar 31, 2011 | 2.64 Bn |
| Dec 31, 2010 | 2.60 Bn |
| Sep 30, 2010 | 2.43 Bn |
| Jun 30, 2010 | 2.32 Bn |
| Mar 31, 2010 | 2.66 Bn |
| Dec 31, 2009 | 2.99 Bn |
| Sep 30, 2009 | 3.06 Bn |